Serial Number | 98336943 |
Word Mark | RIVALS |
Filing Date | Saturday, December 30, 2023 |
Status | 645 - FINAL REFUSAL - MAILED |
Status Date | Wednesday, October 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Vitamin supplements; Herbal supplements; Dietary supplements; Nutritional supplements |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, December 30, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Friday, December 31, 2021 |
First Use In Commerce Date | Saturday, December 31, 2022 |
Party Name | RIVALS L.L.C |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Sheridan, WY 82801 |
Event Date | Event Description |
Saturday, December 30, 2023 | NEW APPLICATION ENTERED |
Monday, April 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, July 30, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, July 30, 2024 | NON-FINAL ACTION WRITTEN |
Monday, July 29, 2024 | ASSIGNED TO EXAMINER |
Tuesday, July 30, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, October 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, October 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 29, 2024 | ASSIGNED TO LIE |
Wednesday, October 30, 2024 | FINAL REFUSAL E-MAILED |
Wednesday, October 30, 2024 | FINAL REFUSAL WRITTEN |
Wednesday, October 30, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Tuesday, July 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |